Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00312078 · ClinicalTrials.gov registry record · NA
Effect of Yogurt on Minimal Hepatic Encephalopathy
A NA study of Cirrhosis and Minimal Hepatic Encephalopathy, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00312078: Completed NA study of Cirrhosis and Minimal Hepatic Encephalopathy, sponsored by Medical College of Wisconsin.
NCT00312078 is a NA study of Cirrhosis and Minimal Hepatic Encephalopathy that has completed, run by Medical College of Wisconsin. The registered enrollment target is 30 participants, below the 90,408-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00312078, a NA study of Cirrhosis and Minimal Hepatic Encephalopathy, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a special yogurt can improve performance on certain tests of intelligence and decrease liver inflammation in patients with cirrhosis.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Yogurt Supplementation
Study Locations (1)
Wisconsin
- GCRC Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-11 |
| Est. Completion | 2007-04 |
| Phase | NA |
What the finished NCT00312078 record still lists
NCT00312078 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 90,408-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Cirrhosis appearing as the primary indexed condition, and to 1 intervention - of which Yogurt Supplementation is the first listed.
NCT00312078 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00312078 about?
NCT00312078 is a clinical study titled "Effect of Yogurt on Minimal Hepatic Encephalopathy". The purpose of this study is to determine whether a special yogurt can improve performance on certain tests of intelligence and decrease liver inflammation in patients with cirrhosis.
What is the current status of trial NCT00312078?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2005-11. Estimated completion is 2007-04.
What conditions does trial NCT00312078 study?
This clinical trial studies the following conditions: Cirrhosis, Minimal Hepatic Encephalopathy.
What interventions are being tested in trial NCT00312078?
The interventions under investigation include: Yogurt Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00312078?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00312078 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00312078's enrollment target sits among peer trials
30 31st of 53 higher than 13 of 53 other Cirrhosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cirrhosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
RECRUITING · NA
-
Copper Supplementation in Cirrhosis
RECRUITING · NA
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
RECRUITING · NA
-
CirrhosisRx CDS System
RECRUITING · NA
-
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
RECRUITING · NA
-
Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia